AZT Public Offer now open....
A General Public Offer to raise up to A$10,000,000 has commenced, with the funds raised being primarily used to:
Market and sell clinically proven nutraceutical products to deliver early revenues; and
Continue clinical trials of two drug candidates for Non-Alcoholic Fatty Liver Disease (NAFLD) and Pancreatic Cancer.